Trichosanthin inhibits cervical cancer by regulating oxidative stress-induced apoptosis

References

• Saei GNM, Kariman N, Ebadi A, et al. Educational interventions for cervical cancer screening behavior of women: a systematic review. Asian Pac J Cancer Prev. 2018;19(4):875–884.
   PubMedGoogle Scholar
• Wj S, Ma B, Bajaj A, et al. Cervical cancer: a global health crisis. Cancer-Am Cancer Soc. 2017;123(13):2404–2412.
   PubMed Web of Science ®Google Scholar
• Li J, Gao JJ, Li N, et al. Distribution of human papillomavirus genotypes in western China and their association with cervical cancer and precancerous lesions. Arch Virol. 2021;166, 853–862.
   Web of Science ®Google Scholar
• Chesson HW, Laprise JF, Brisson M, et al. The estimated lifetime medical cost of diseases attributable to human Papillomavirus infections acquired in 2018. Sex Transm Dis. 2021;48(4):278-284.
   Web of Science ®Google Scholar
• Simms KT, Steinberg J, Caruana M, et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study. Lancet Oncol. 2019;20(3):394–407.
   PubMed Web of Science ®Google Scholar
• Gaber G, El AS, Khedr GA, et al. Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy. Am J Clin Oncol. 2021;44(2):58–67.
   PubMed Web of Science ®Google Scholar
• Naga CP, Gurram L, Chopra S, et al. The management of locally advanced cervical cancer. Curr Opin Oncol. 2018;30(5):323–329.
   PubMed Web of Science ®Google Scholar
• Gennari P, Gerken M, Meszaros J, et al. Minimal-invasive or open approach for surgery of early cervical cancer: the treatment center matters. Arch Gynecol Obstet. 2021. DOI:10.1007/s00404-020-05947-y
   PubMed Web of Science ®Google Scholar
• Gokalp F. The effective natural compounds for inhibiting Cervical cancer. Med Oncol. 2021;38(2):12.
   PubMed Web of Science ®Google Scholar
• Rosen VM, Guerra I, McCormack M, et al. Systematic review and network meta-analysis of Bevacizumab plus first-line Topotecan-Paclitaxel or Cisplatin-Paclitaxel versus Non-Bevacizumab-containing therapies in persistent, recurrent, or metastatic cervical cancer. Int J Gynecol Cancer. 2017;27(6):1237–1246.
   PubMed Web of Science ®Google Scholar
• Zhang XJ, Wang JH. Homology of trichosanthin and ricin A chain. Nature. 1986;321(6069):477–478.
   PubMed Web of Science ®Google Scholar
• Wang W, Tan B, Zhang J, et al. Human nasopharyngeal carcinoma can be radiosensitized by trichosanthin via inhibition of the PI3K pathway. Exp Ther Med. 2018;16(5):4181–4186.
   PubMed Web of Science ®Google Scholar
• Cai Y, Xiong S, Zheng Y, et al. Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM. Cell Mol Immunol. 2011;8(4):359–367.
   PubMed Web of Science ®Google Scholar
• You C, Sun Y, Zhang S, et al. Trichosanthin enhances sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistance cells. Int J Biol Sci. 2018;14(2):217–227.
   PubMed Web of Science ®Google Scholar
• Zhao WL, Feng D, Wu J, et al. Trichosanthin inhibits integration of human immunodeficiency virus type 1 through depurinating the long-terminal repeats. Mol Biol Rep. 2010;37(4):2093–2098.
   PubMed Web of Science ®Google Scholar
• You C, Sun Y, Zhang S, et al. Trichosanthin enhances sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistance cells. Int J Biol Sci. 2018;14(2):217–227.
   PubMed Web of Science ®Google Scholar
• Lin B, Yang XZ, Cao XW, et al. A novel trichosanthin fusion protein with increased cytotoxicity to tumor cells. Biotechnol Lett. 2017;39(1):71–78.
   PubMed Web of Science ®Google Scholar
• Miao J, Jiang Y, Wang D, et al. Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt/beta-catenin signaling pathway. Oncol Rep. 2015;34(6):2845–2852.
   PubMed Web of Science ®Google Scholar
• Cui L, Song J, Wu L, et al. Smac is another pathway in the anti-tumour activity of Trichosanthin and reverses Trichosanthin resistance in CaSki cervical cancer cells. Biomed Pharmacother. 2015;69:119–124.
   PubMed Web of Science ®Google Scholar
• Wang P, Xu J, Zhang C. CREB, a possible upstream regulator of Bcl-2 in trichosanthin-induced HeLa cell apoptosis. Mol Biol Rep. 2010;37(4):1891–1896.
   PubMed Web of Science ®Google Scholar
• Cheng X, Feng H, Wu H, et al. Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer. Cancer Lett. 2018;431:105–114.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhu L, Guo X. Valproic acid attenuates Abeta25–35–induced neurotoxicity in PC12 cells through suppression of mitochondria-mediated apoptotic pathway. Biomed Pharmacother. 2018;106:77–82.
   PubMed Web of Science ®Google Scholar
• Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211–218.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. Ca Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Liu K, Xue B, Bai G, et al. Downregulation of Diacylglycerol kinase zeta (DGKZ) suppresses tumorigenesis and progression of cervical cancer by facilitating cell apoptosis and cell cycle arrest. Bioengineered. 2021;12(1):1517–1529.
   PubMed Web of Science ®Google Scholar
• Gu Q, Hou W, Shi L, et al. RNA ZNF609 functions as a competing endogenous RNA in regulating E2F transcription factor 6 through competitively binding to microRNA–197–3p to promote the progression of cervical cancer progression. Bioengineered. 2021;12(1):927–936.
   PubMed Web of Science ®Google Scholar
• Liu H, Song M, Sun X, et al. T-box transcription factor TBX1, targeted by microRNA–6727–5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways. Bioengineered. 2021;12(1):565–577.
   PubMed Web of Science ®Google Scholar
• Cui L, Song J, Wu L, et al. Smac is another pathway in the anti-tumour activity of Trichosanthin and reverses Trichosanthin resistance in CaSki cervical cancer cells. Biomed Pharmacother. 2015;69:119–124.
   PubMed Web of Science ®Google Scholar
• Dai X, Jiang P, Ji Y, et al. Suppression of murine B-cell lymphoma growth by trichosanthin through anti-angiogenesis. Am J Transl Res. 2019;11(6):3567–3577.
   PubMed Web of Science ®Google Scholar
• Chen Y, Han L, Bai L, et al. Trichosanthin inhibits the proliferation of cervical cancer cells and downregulates STAT-5/C-myc signaling pathway. Pathol Res Pract. 2019;215(4):632–638.
   PubMed Web of Science ®Google Scholar
• Miao J, Jiang Y, Wang D, et al. Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt/beta-catenin signaling pathway. Oncol Rep. 2015;34(6):2845–2852.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Sun Y, Cai Y, et al. Trichosanthin reduces the viability of SUDHL2 cells via the activation of the extrinsic and intrinsic apoptotic pathways. Mol Med Rep. 2016;13(1):403–411.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Bai T, Shen S, et al. Increase of cytosolic calcium induced by trichosanthin suppresses cAMP/PKC levels through the inhibition of adenylyl cyclase activity in HeLa cells. Mol Biol Rep. 2011;38(4):2863–2868.
   PubMed Web of Science ®Google Scholar
• Wang P, Chen LL, Yan H, et al. Trichosanthin suppresses HeLa cell proliferation through inhibition of the PKC/MAPK signaling pathway. Cell Biol Toxicol. 2009;25(5):479–488.
   PubMed Web of Science ®Google Scholar
• Chu N, Yao G, Liu Y, et al. Newly synthesized bis-benzimidazole compound 8 induces apoptosis, autophagy and reactive oxygen species generation in HeLa cells. Bioorg Med Chem Lett. 2016;26(17):4367–4371.
   PubMed Web of Science ®Google Scholar
• Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281(5381):1312–1316.
   PubMed Web of Science ®Google Scholar
• Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 1999;6(11):1028–1042.
   PubMed Web of Science ®Google Scholar
• Stennicke HR, Salvesen GS. Caspases - controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta. 2000;1477(1–2):299–306.
   PubMedGoogle Scholar
• Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene. 2003;22(53):8543–8567.
   PubMed Web of Science ®Google Scholar
• Xu C, Wang X, Zhu Y, et al. Rapamycin ameliorates cadmium-induced activation of MAPK pathway and neuronal apoptosis by preventing mitochondrial ROS inactivation of PP2A. Neuropharmacology. 2016;105:270–284.
   PubMed Web of Science ®Google Scholar
• Li J, Yu W, Li XT, et al. The effects of propofol on mitochondrial dysfunction following focal cerebral ischemia-reperfusion in rats. Neuropharmacology. 2014;77:358–368.
   PubMed Web of Science ®Google Scholar
• Sanderson TH, Reynolds CA, Kumar R, et al. Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol. 2013;47(1):9–23.
   PubMed Web of Science ®Google Scholar
• Tao L, Li X, Zhang L, et al. Protective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway. Plos One. 2011;6(10):e26055.
   PubMed Web of Science ®Google Scholar